Genentech Helps Pulmonary Fibrosis Foundation Programs

Marta Ribeiro avatar

by Marta Ribeiro |

Share this article:

Share article via email



The Pulmonary Fibrosis Foundation (PFF), an organization whose goal is to raise awareness, offer disease education, advance care, and fund research in the field of pulmonary fibrosis (PF), announced in a press release that Genentech, a biotechnology company part of the Roche Group, will assume the role of Founding Partner on the PFF Patient Registry program. Genentech will fund both the PFF Patient Registry and the PFF Care Center Network’s (CCN) signature programs.


Read more about:

Your PF Community

Woman laying down reading

Visit the Pulmonary Fibrosis News forums to connect with others in the PF community.

View Forums